Serotonergic systems

Psychiatric Clinics of North America

Volumn 20, Issue 4, 1997, Pages 723-739

  Graeff, F G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 METHOXYTRYPTAMINE; KETANSERIN; MESULERGINE; METITEPINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; ONDANSETRON; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN;

AUTORADIOGRAPHY; CENTRAL NERVOUS SYSTEM; ELECTROPHYSIOLOGY; HUMAN; MEDICAL PRACTICE; NERVE FIBER TRANSPORT; NEUROANATOMY; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REVIEW; SEROTONINERGIC SYSTEM;

EID: 0031445354     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70342-7     Document Type: Article

References (73)

1. G.K. Aghajanian Central 5-HT receptor subtypes: Physiological responses and signal transduction mechanisms C.A. Marsden D.J. Heal Central Serotonin Receptors and Psychotropic Drugs 1992 Blackwell Scientific Publications Oxford 39 55
2. F. Artigas 5-HT and antidepressants: New views from microdialysis studies Trends Pharmacol Sci 14 1993 262
3. F. Artigas V. Perez E. Alvarez Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors Arch Gen Psychiatry 51 1994 248 251
4. M. Asberg D. Schalling L. Traskman-Bendz Psychobiology of suicide, impulsivity, and related phenomena H.Y. Meltzer Psychopharmacology. Third Generation of Progress 1987 Raven Press New York 655 668
5. E.C. Azmitia The serotonin-producing neurons of the midbrain median and dorsal raphe nuclei L.L. Iversen S.D. Iversen S.H. Snyder Handbook of Psychopharmacology, vol. 9: Chemical Pathways in the Brain 1978 Plenum Press New York 233 314
6. C.M. Beasley D.N. Masica J.H. Potvin Fluoxetine: A review of receptor and functional effect and their clinical implications Psychopharmacology 107 1992 1 10
7. M.A. Blackshear L.L. Martin E. Sanders-Bush Adaptive changes in the 5-HT2 binding site after chronic administration of agonists and antagonists Neuropharmacology 25 1986 1267 1271
8. P. Blier C. de Montigny Y. Chaput Modification of the serotonin system by the antidepressant treatments: Implications for the therapeutic response in major depression J Clin Psychopharmacol 7 1987 24S 35S
9. G. Bonnano A. Fassio P. Severi Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism J Neurochem 63 1994 1163 1166
10. 1A receptors on neurones of the rat midbrain tectum Brain Res 556 1991 259 266
11. W.F. Byerley L.L. Judd F.W. Reimherr 5-Hydroxytryptophan: A review of its antidepressant efficacy and adverse effects J Clin Psychopharmacol 7 1987 127 137
12. D.L.S. Ceulemans M.L.J.A. Hoppenbrouwers Y.G. Gelders The influence of ritanserin, a serotonin antagonist in anxiety disorders: A double-blind placebo-controlled study versus lorazepam Pharmacopsychiatry 18 1985 303 305
13. 1B/1D receptor ligands Pharmacol Ther 62 1994 385 405
14. A. Coppen The biochemistry of affective disorders Br J Psychiatry 113 1967 1237 1264
15. J. Cowen Psychotropic drugs and human 5-HT neuroendocrinology Trends Pharmacol Sci 8 1987 105 108
16. J.F.W. Deakin 5-HT receptor subtypes in depression T. Archer P. Bevan A. Cools Behavioral Pharmacology of 5–HT. Hillsdale 1989 Lawrence Erlbaum Associates 179 204
17. J.F.W. Deakin F.G. Graeff 5-HT and mechanisms of defence J Psychopharmacol 5 1991 305 315
18. P.L. Delgado D.S. Charney L.H. Price Serotonin function and the mechanism of antidepressant action Arch Gen Psychiatry 47 1990 411 418
19. J.A. Den Boer H.G.M. Westenberg Serotonin function in panic disorder: A double-blind placebo controlled study with fluvoxamine and ritanserin Psychopharmacology 102 1990 85 94
20. A.S. Eison D.L. Temple Buspirone: Review of its pharmacology and current perspectives on the mechanism of action Am J Med 80 suppl 3B 1989 1 9
21. E. Eriksson M. Humble Serotonin in psychiatric pathophysiology R. Pohl S. Gershon The Biological Basis of Psychiatric Treatment. Progress in Basic and Clinical Pharmacology vol. 3 1990 Karger Basel 66 119
22. R.W. Fuller H.D. Snoddy D.W. Robertson Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release Pharmacol Biochem Behav 30 1988 715 721
23. J.H. Gaddum Z.P. Picarelli Two types of tryptamine recetor Br J Pharmacol Chemother 12 1957 323 328
24. V. Gentil F. Lotufo-Neto L. Andrade Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine J Psychopharmacol 7 1993 316 324
25. F.G. Graeff Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety M. Briley S.E. File New Concepts in Anxiety 1991 MacMillan Press London 288 312
26. F.G. Graeff Role of 5-HT in defensive behavior and anxiety Rev Neurosci 4 1993 181 211
27. F.G. Graeff F.S. Guimarães T.G.C.S. de Andrade Role of 5-HT in stress, anxiety and depression Pharmacol Biochem Behav 54 1996 129 141
28. F.G. Graeff M.C.L. Silveira R.I. Nogueira Role of the amygdala and periaqueductal gray in anxiety and panic Behav Brain Res 58 1993 123 131
29. F.S. Guimarães A.W. Zuardi F.G. Graeff Effect of chlorimipramine and maprotiline on experimental anxiety in humans J Psychopharmacol 1 1987 184 192
30. S.L. Handley S. Mithani Effects of alpha-adrenoceptor agonists in a maze-exploration model of “fear”-motivated behaviour Naunyn Schmiedebergs Arch Pharmacol 327 1984 1 5
31. D. Hoyer D.E. Clarke J.R. Fozard VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 46 1994 157 203
32. Humble M, A“berg-Wistedt B, Bertilson L: A pilot study of ritanserin (a selective serotonin-2 receptor antagonist) in panic disorder and agoraphobia: Clinical and biochemical effects [abstract P-165]. Fifteenth CINP Congress, San Juan, Puerto Rico, 1986
33. P.P.A. Humphrey P. Hartig D. Hoyer A proposed new nomenclature for 5-HT receptors Trends Pharmacol Sci 14 1993 233 236
34. R. Invernizzi S. Belli R. Samanin An increase of extracellular serotonin in the dorsal raphé masks the effect of sertraline in the frontal cortex H. Rollema B. Westering W.J. Drijfhout Monitoring Molecules in Neuroscience 1992 University Center for Pharmacy Groeningen 253 255
35. B.L. Jacobs An animal behavior model for studying central serotonergic synapses Life Sci 19 1976 777 786
36. B.L. Jacobs C.A. Fornal Activity of brain serotonergic neurons in the behaving animal Pharmacol Rev 43 1991 563 578
37. R.J. Kahn D.M. MacNair R.S. Lipman Imipramine and chlordiazepoxide in depressive and anxiety disorders: II. Efficacy in anxious outpatients Arch Gen Psychiatry 43 1986 79 85
38. R.S. Kahn H.M. van Praag S. Wetzler Serotonin and anxiety revisited Biol Psychiatry 23 1988 189 208
39. R.S. Kahn H.G.M. Westenberg W.M.A. Verhoeven Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo Int Clin Psychopharmacol 2 1987 89 94
40. 1C receptors and their therapeutic relevance Curr Opin Invest Drugs 2 1993 317 362
41. G.A. Kennett D. Bailey D.C. Piper Effect of SB 200646A, A 5-HT2C/5-HT2B receptor antagonist in two conflict models of anxiety Psychopharmacology 118 1995 178 182
42. S.Z. Langer Association of [3H] imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: Relevance to studies in depression J Recept Res 7 1987 499 521
43. J.E. Leysen P. van Gompel W. Gommeren Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin S-2 antagonists: Ritanserin and stoperone Psychopharmacology 88 1986 434 444
44. I. Lucki 5-HT1 receptors and behaviour Neurosci Biobehav Rev 16 1992 83 93
45. L.A. Mamounas C.A. Mullen E. O'Hearn Dual serotonergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives J Comp Neurol 314 1991 558 586
46. R. Mongeau P. Blier C. de Montigny The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments Brain Res Bull 23 1997 145 195
47. D.L. Murphy T.A. Pigott T.R. Insel Obsessive-compulsive disorder and anxiety G.D. Burrows M. Roth R. Noyes Jr Handbook of Anxiety, vol 3: The Neurobiology of Anxiety 1990 Elsevier Science Publishers Amsterdam 269 287
48. D.L. Murphy T.A. Pigott T.A. Grady Neuropharmacological investigations of brain serotonin subsystem functions in obsessive compulsive disorder Advances in Biosciences 85 1992 271 285
49. Y.G. Ni R. Miledi Blockade of 5HT2C serotonin receptors by fluoxetine (Prozac) Proc Natl Acad Sci USA 94 1997 2036 2040
50. D.E. Nichols D. Marona-Lewicka X. Huang M.P. Johnson Novel serotonergic agents Drug Des Discov 9 1993 299 312
51. D.J. Nutt Anxiety and its therapy: Today and tomorrow M. Briley S.E. File New Concepts in Anxiety 1991 MacMillan Press London 1 12
52. J.C. Pecknold Serotonin 5-HT1A agonists: A comparative review CNS Drugs 2 1994 234 251
53. S. Peroutka 5-HT receptors: Past, present and future Trends Neurosci 18 1995 68 69
54. M. Raitieri G. Bonanno F. Vallebuona In vitro and in vivo effects of d-fenfluramine: No apparent relation between 5-hydroxytryptamine release and hypophagia J Pharmacol Exp Ther 273 1995 643 649
55. J.L. Rapoport Recent advances in obsessive-compulsive disorder Neuropsychopharmacology 5 1991 1 10
56. A. Rex C.A. Marsden H. Fink Increased 5-HT release in the guinea-pig frontal cortex on exposure to the X-maze H. Rollema B.H.C. Westering W.J. Drijfhout Monitoring Molecules in Neuroscience 1991 University Centre for Pharmacy Groningen 250 252
57. 2 receptor antagonist J Pharmacol Exp Ther 262 1992 759 767
58. 3 Antagonists and Benzodiazepines: Their Comparative Behavioural Pharmacology 1991 John Wiley & Sons Chichester 365 376
59. B. Shopsin E. Friedman M. Goldstein Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients Arch Gen Psychiatry 33 1976 811 819
60. B. Shopsin E. Friedman M. Goldstein The uses of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients Psychopharmacol Commun 1 1975 239 249
61. Siever L.J. Kahn R.S. Lowlor B.A. Critical issues in defining the role of serotonin in psychiatric disorders: II Pharmacol Rev 43 1991 509 525
62. V.B. Singh E.S. Onaivi T.-H. Phan M.C. Boadle-Biber The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute ot repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala Brain Res 530 1990 49 53
63. 1A agonists and L-5-HTP in Montgomery's conflict test Pharmacol Biochem Behav 32 1989 259 265
64. P. Soubrié Reconciling the role of central serotonin neurons in human and animal behavior Behav Brain Sci 9 1986 319 364
65. J.M. Stutzmann B. Eon F. Darche Are 5-HT2 antagonists endowed with anxiolytic properties in rodents? Neurosci Lett 128 1991 4 8
66. J. Thomson H. Rankin G.W. Ashcroft The treatment of depression in general practice: A comparison of L-tryptophan, amitryptiline, and a combination of L-tryptophan and amitryptiline with placebo Psychol Med 12 1982 741 751
67. D.M. Tomkins B. Costall M.E. Kelly Release of suppressed behaviour of rat on the elevated X-maze by 5-HT3 receptor antagonists injected into the basolateral amygdala J Psychopharmacol 4 1990 262
68. 1A receptor-related anxiolytics Trends Pharmacol Sci 8 1987 432 437
69. J. Vetulani R.J. Stawarz J.V. Dingell A possible common mechanism of action of antidepressant treatments: Reduction in sensitivity of noradrenergic cyclic AMP generating system in the rat limbic forebrain Naunnyn Schmiedebergs Arch Pharmacol 293 1976 109 114
70. H. Walletschek A. Raab Spontaneous activity of dorsal raphe neurons during defensive and offensive encounters in the tree-shrew Physiol Behav 28 1981 697 705
71. I.K. Wright N. Upton C.A. Marsden Effect of potential anxiolytics on extracellular 5-HT in the ventral hippocampus observed of rats on the elevated x-maze using in vivo microdialysis H. Rollema B.H.C. Westering W.J. Drijfhout Monitoring Molecules in Neuroscience 1991 University Centre for Pharmacy Groningen 208 211
72. I.K. Wright M. Heaton N. Upton Comparison of acute and chronic treatment of diazepam and ritanserin in the elevated plus-maze model of anxiety M. Briley S.E. File New Concepts in Anxiety 1991 Macmillan London 277 287
73. E. Zifa G. Fillion 5-Hydroxytryptamine receptors Pharmacol Rev 44 1992 401 458